|
DK0810209T3
(da)
|
1992-08-25 |
2002-08-12 |
Monsanto Co |
Alpha - and beta-aminosyre-hydroxyethylaminosulfonamider til anvendelse som inhibitorer af retrovirale proteaser
|
|
SK283878B6
(sk)
|
1996-01-26 |
2004-04-06 |
Virco B.V.B.A. |
In vitro spôsob určenia HIV chemoterapie HIV pozitívnych pacientov
|
|
US6242187B1
(en)
|
1996-01-29 |
2001-06-05 |
Virologic, Inc. |
Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening
|
|
KR20010022420A
(ko)
*
|
1997-07-30 |
2001-03-15 |
추후제출 |
항 바이러스성 약품의 민감성과 내성의 결정 및 항바이러스성 약품의 스크리닝을 위한 조성물 및 방법
|
|
AU3474499A
(en)
*
|
1998-04-07 |
1999-10-25 |
Southern Research Institute |
High-throughput method for screening for antiviral activity
|
|
US7037644B1
(en)
|
1998-05-26 |
2006-05-02 |
Virologic, Inc. |
Means and methods for monitoring non-nucleoside reverse transcriptase inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of HIV/AIDS
|
|
BR9911600A
(pt)
*
|
1998-05-26 |
2001-02-13 |
Virologic Inc |
Recursos e métodos para monitoração de terapia antiretroviral inibidora de transcriptase reversa de não nucleosìdeo
|
|
ATE290605T1
(de)
*
|
1998-06-19 |
2005-03-15 |
Us Gov Health & Human Serv |
Verfahren und reagentiensatz zur erkennung von antiviralen wirkstoff resistenzen
|
|
US20030148307A1
(en)
|
1998-06-19 |
2003-08-07 |
Department Of Health & Human Services, C/O Centers Of Disease Control And Prevention |
Method and kit for detecting resistance to antiviral drugs
|
|
US6787126B1
(en)
|
1998-06-19 |
2004-09-07 |
The United States Of America As Represented By The Department Of Health And Human Services |
Method and kit for detecting resistance to antiviral drugs
|
|
MXPA00012843A
(es)
*
|
1998-06-24 |
2002-04-24 |
Virologic Inc |
Medios y metodo para verificar la terapia antirretroviral con un inhibidor nucleosico de la transcriptasa inversa y guia de decisiones terapeuticas en el tratamiento del vih/sida.
|
|
EP1185712B8
(en)
|
1999-05-28 |
2005-10-19 |
Virco Bvba |
New mutational profiles in hiv-1 reverse transcriptase correlated with phenotypic drug resistance
|
|
EP1326640A4
(en)
*
|
2000-09-15 |
2004-12-15 |
Virologic Inc |
NON-NUCLEOSIDIC REVERSE-TRANSCRIPTASE INHIBITOR AS ANTIRETROVIRAL THERAPY
|
|
AU2631602A
(en)
|
2000-10-20 |
2002-04-29 |
Virco Nv |
New mutational profiles in hiv-1 reverse transcriptase correlated with phenotypic drug resistance
|
|
ES2321809T3
(es)
|
2000-10-20 |
2009-06-12 |
Virco Bvba |
Establecimiento de valores e corte biologicos para predecir la resistencia a la terapia.
|
|
US7097970B2
(en)
|
2001-06-04 |
2006-08-29 |
Monogram Biosciences, Inc. |
Methods of evaluating viral entry inhibitors using patient derived envelope protein constructs
|
|
US7247439B1
(en)
|
2001-06-04 |
2007-07-24 |
Monogram Biosciences, Inc. |
Method of evaluating a patient antibody response to envelope proteins of a virus
|
|
ATE389029T1
(de)
|
2001-11-08 |
2008-03-15 |
Tibotec Pharm Ltd |
Protease assay zur kontrolle medikamentöser therapie
|
|
ATE397669T1
(de)
|
2002-07-01 |
2008-06-15 |
Tibotec Pharm Ltd |
Mit phänotypischer medikamentenresistenz korrelierte mutationsprofile in hiv-1-reverse- transkriptase
|
|
WO2004003817A1
(en)
|
2002-07-01 |
2004-01-08 |
Tibotec Pharmaceuticals Ltd. |
Mutational profiles in hiv-1 protease correlated with phenotypic drug resistance
|
|
DE20218008U1
(de)
|
2002-11-21 |
2003-03-06 |
FESTO AG & Co., 73734 Esslingen |
Anordnung von mehreren Handhabungsvorrichtungen
|
|
US8603736B2
(en)
|
2004-06-07 |
2013-12-10 |
Monogram Biosciences, Inc. |
Compositions and methods for determining resistance to inhibitors of virus entry using recombinant virus assays
|
|
WO2006089045A2
(en)
|
2005-02-18 |
2006-08-24 |
Monogram Biosciences, Inc. |
Methods and compositions for determining hypersusceptibility of hiv-1 to non-nucleoside reverse transcriptase inhibitors
|
|
CA2601922C
(en)
|
2005-02-18 |
2020-11-24 |
Monogram Biosciences, Inc. |
Methods and compositions for determining anti-hiv drug susceptibility and replication capacity of hiv
|
|
WO2006130477A2
(en)
|
2005-05-27 |
2006-12-07 |
Monogram Biosciences, Inc. |
Methods and compositions for determining resistance of hiv-1 to protease inhibitors
|
|
WO2006133267A2
(en)
|
2005-06-06 |
2006-12-14 |
Monogram Biosciences, Inc. |
Methods and compositions for determining altered susceptibility of hiv-1 to anti-hiv drugs
|
|
US9506121B2
(en)
|
2005-06-06 |
2016-11-29 |
Monogram Biosciences, Inc. |
Methods for determining resistance or susceptibility to HIV entry inhibitors
|
|
WO2007146336A2
(en)
|
2006-06-13 |
2007-12-21 |
Monogram Biosciences, Inc. |
Molecular determinants associated with enhanced ability to enter cells expressing cxcr4
|
|
US8338101B2
(en)
*
|
2007-01-23 |
2012-12-25 |
Virco Bvba |
Method for designing a drug regime for HIV-infected patients
|
|
WO2008106115A2
(en)
|
2007-02-26 |
2008-09-04 |
Monogram Biosciences, Inc. |
Compositions and methods for determining whether a subject would benefit from co-receptor inhibitor therapy
|
|
WO2018030534A1
(ja)
|
2016-08-10 |
2018-02-15 |
国立研究開発法人理化学研究所 |
Ｂ型肝炎治療用組成物、及びｂ型肝炎ウイルスの複製活性の評価方法
|
|
RU2646472C1
(ru)
*
|
2016-10-07 |
2018-03-05 |
Федеральное государственное бюджетное образовательное учреждение высшего образования "Пермский государственный медицинский университет имени академика Е.А. Вагнера" Министерства здравоохранения Российской Федерации |
Способ оценки эффективности терапии инфекции вызванной вирусом герпеса человека 6 типа у детей
|
|
CN110382009A
(zh)
*
|
2016-12-29 |
2019-10-25 |
富荣吉有限责任公司 |
Retro-HBV和Lenti-HBV的混合载体及构建体
|
|
CN109722465B
(zh)
*
|
2019-01-07 |
2022-02-01 |
福建省疾病预防控制中心(福建省健康教育促进中心、福建省卫生检验检测中心) |
一种hiv耐药检测载体和构建方法
|
|
JP7773731B2
(ja)
*
|
2020-06-24 |
2025-11-20 |
シァメン・ユニヴァーシティ |
薬物スクリーニングモデル及びＨＢＶ ｃｃｃＤＮＡを標的化する方法
|